GE Healthcare unveiled at RSNA 2009 a software technique that uses low-frequency sound waves in combination with MRI to measure the elasticity of liver tissue as an indicator of disease.
GE Healthcare unveiled at RSNA 2009 a software technique that uses low-frequency sound waves in combination with MRI to measure the elasticity of liver tissue as an indicator of disease. The technology underlying this new product, called MR-Touch, was developed at the Mayo Clinic in Rochester, MN, and licensed to GE. It extends the principles of physical palpation and MR as a way to evaluate tissue stiffness.
GE is framing MR-Touch as a precise, noninvasive and cost-effective way to detect, monitor, and understand disease. The FDA-cleared technique detects changes in the liver that indicate the presence of disease. It can also be used to monitor disease progression and provide more informed preventive guidance. Perhaps most important, the method supports a comfortable experience for the patient.
MR-Touch will be commercially available as an option to GE's newly released wide-bore 1.5T MR scanner, the Optima MR450w.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.